Efficacy and Safety of Hetrombopag in Non-severe Aplastic Anemia | MicrobiomeTrials← Back to trialsNCT05018936
Efficacy and Safety of Hetrombopag in Non-severe Aplastic Anemia
WITHDRAWNPHASE2, PHASE3INTERVENTIONAL
Trial Details
Start: 2021-10-01Est. Completion: 2023-10-01
Enrollment target: 0 participants Locations- Peking Union Medical College Hospital, Beijing, China
Other microbiome trials you might be interested in
Severe Aplastic Anemia (SAA)Hypo-Plastic Myelodysplastic Syndrome (MDS)Paroxysmal Nocturnal Hemoglobinuria (PNH)
Background:
Severe aplastic anemia (SAA), and myelodysplastic syndrome (MDS), and paroxysmal nocturnal hemoglobinuria
…
Bethesda, United StatesEst. completion Jun 1, 2027
Aplastic AnemiasHemoglobinopathiesBone Marrow Failure
A prospective, multicenter study that will establish a repository of biospecimens and clinical data from patients underg…
Gainesville, United StatesEst. completion Mar 30, 2031
MelanomaLi-Fraumeni SyndromePulmonary BlastomaChordomaCongenital Bone Marrow Failure SyndromesCostello SyndromeFanconi AnemiaCFC Syndrome (CFCS)Legius SyndromeRASopathies
Background:
Clinical Genetics Branch (CGB) researchers study individuals and populations at high genetic risk of cancer…
Rockville, United StatesEst. completion Jan 1, 2035